Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Courchesne E. (1995). New Evidence of Cerebellar and Brainstem Hypoplasia in
Autistic Infants, Children and Adolescents: The MR Imaging Study by Hashimoto
and Colleagues. J. Autism Dev Disord, 25: 19–22.
Couve A, Thomas P, Calver AR, Hirst WD, Pangalos MN, Walsh FS, Smart TG,
Moss SJ. (2002). Cyclic AMP–dependent protein kinase phosphorylation
facilitates GABA (B) receptor–effector coupling. Nat Neurosci, 5: 415–424.
Coyle JT, Price DL, DeLong MR. (1983). Alzheimer’s disease: a disorder of cortical
cholinergic innervation. Science, 219: 1184–1190.
Crossman AR, Mitchell IJ, Sambrook MA, Jackson A. (1988). Chorea and myoclonus
in the monkey induced by gamma–aminobutyric acid antagonism in the lentiform
complex. The site of drug action and a hypothesis for the neural mechanisms of
chorea. Brain, 111: 1211–1233.
Cryer PE, Davis SN, Shamoon H. (2003). Hypoglycemia in diabetes. Diabetes Care,
26: 1902–1912.
Cryer PE. (1994). Banting Lecture. Hypoglycemia: the limiting factor in the
management of IDDM. Diabetes, 43: 1378–1389.
Cryer PE, Polonsky KS. (1998). Glucose homeostasis and hypoglycemia. In: Williams
textbook of endocrinology, 9th edition (Wilson JD, Foster DW, eds),
Philadelphia: WB Saunders Co. p 939–971.
Cryer PE. (2002a). Hypoglycaemia: the limiting factor in the glycaemic management
of Type I and Type II diabetes. Diabetologia, 45: 937–948.